Concepts (111)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Neoplastic Cells, Circulating | 1 | 2018 | 68 | 0.69 | Why? |
| Seroconversion | 2 | 2021 | 2515 | 0.46 | Why? |
| Kidney Tubules, Proximal | 2 | 2021 | 178 | 0.39 | Why? |
| Nocardia Infections | 2 | 2018 | 37 | 0.35 | Why? |
| Kidney Transplantation | 3 | 2021 | 5397 | 0.33 | Why? |
| Belgium | 9 | 2021 | 2064 | 0.31 | Why? |
| Immunocompromised Host | 1 | 2021 | 5150 | 0.27 | Why? |
| Lung Neoplasms | 1 | 2018 | 3228 | 0.21 | Why? |
| Respiratory Insufficiency | 1 | 2021 | 7301 | 0.20 | Why? |
| Pneumocystis | 1 | 2018 | 9 | 0.19 | Why? |
| Leprosy, Multibacillary | 1 | 2018 | 4 | 0.19 | Why? |
| Paget Disease, Extramammary | 1 | 2018 | 10 | 0.19 | Why? |
| Mycobacterium leprae | 1 | 2018 | 20 | 0.18 | Why? |
| Pulmonary Embolism | 1 | 2018 | 4775 | 0.18 | Why? |
| Uric Acid | 1 | 2021 | 285 | 0.18 | Why? |
| Leg Ulcer | 1 | 2018 | 32 | 0.17 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.16 | Why? |
| Exercise Tolerance | 1 | 2021 | 634 | 0.15 | Why? |
| Antibodies, Viral | 4 | 2021 | 51949 | 0.14 | Why? |
| Hospitals, Teaching | 1 | 2021 | 1609 | 0.12 | Why? |
| Exercise Therapy | 1 | 2021 | 976 | 0.12 | Why? |
| Telerehabilitation | 1 | 2021 | 736 | 0.12 | Why? |
| Recovery of Function | 1 | 2021 | 2461 | 0.11 | Why? |
| Convalescence | 1 | 2021 | 2829 | 0.10 | Why? |
| Immunity, Humoral | 2 | 2021 | 4849 | 0.10 | Why? |
| Ambulatory Care Facilities | 1 | 2020 | 2063 | 0.09 | Why? |
| Hydroxychloroquine | 3 | 2021 | 12447 | 0.09 | Why? |
| Hypertension, Pulmonary | 1 | 2018 | 970 | 0.09 | Why? |
| Antimalarials | 1 | 2020 | 2505 | 0.09 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.09 | Why? |
| Body Mass Index | 1 | 2021 | 4306 | 0.09 | Why? |
| Azithromycin | 1 | 2020 | 3943 | 0.07 | Why? |
| Aged | 12 | 2021 | 215776 | 0.07 | Why? |
| Transplant Recipients | 1 | 2021 | 4982 | 0.07 | Why? |
| Severity of Illness Index | 3 | 2021 | 48226 | 0.07 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2018 | 2426 | 0.07 | Why? |
| Adrenal Cortex Hormones | 1 | 2021 | 6537 | 0.07 | Why? |
| Renal Dialysis | 1 | 2020 | 4358 | 0.06 | Why? |
| Immunosuppressive Agents | 1 | 2021 | 6331 | 0.06 | Why? |
| Male | 14 | 2021 | 367725 | 0.06 | Why? |
| Occupational Exposure | 1 | 2021 | 4742 | 0.06 | Why? |
| Postoperative Complications | 1 | 2021 | 5861 | 0.06 | Why? |
| Antibodies, Monoclonal | 1 | 2021 | 8041 | 0.06 | Why? |
| Organic Cation Transport Proteins | 1 | 2021 | 37 | 0.06 | Why? |
| Organic Anion Transporters | 1 | 2021 | 40 | 0.06 | Why? |
| Organ Transplantation | 1 | 2017 | 2616 | 0.06 | Why? |
| Nervous System Diseases | 1 | 2020 | 4092 | 0.06 | Why? |
| Middle Aged | 12 | 2021 | 270681 | 0.06 | Why? |
| Radiographic Image Enhancement | 1 | 2021 | 89 | 0.05 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.05 | Why? |
| Lung | 2 | 2021 | 31049 | 0.05 | Why? |
| Gangliosides | 1 | 2020 | 86 | 0.05 | Why? |
| Spinal Puncture | 1 | 2020 | 95 | 0.05 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.05 | Why? |
| Radiculopathy | 1 | 2020 | 79 | 0.05 | Why? |
| Biological Availability | 1 | 2020 | 388 | 0.05 | Why? |
| Humans | 18 | 2021 | 930598 | 0.05 | Why? |
| Atovaquone | 1 | 2018 | 19 | 0.05 | Why? |
| Leukocytosis | 1 | 2020 | 280 | 0.04 | Why? |
| Nerve Tissue Proteins | 1 | 2020 | 319 | 0.04 | Why? |
| Female | 11 | 2021 | 380317 | 0.04 | Why? |
| Leprostatic Agents | 1 | 2018 | 94 | 0.04 | Why? |
| Odds Ratio | 2 | 2021 | 5861 | 0.04 | Why? |
| Neurologic Examination | 1 | 2020 | 428 | 0.04 | Why? |
| Retrospective Studies | 4 | 2021 | 105322 | 0.04 | Why? |
| Positron-Emission Tomography | 1 | 2021 | 802 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2017 | 10083 | 0.04 | Why? |
| Pregnancy Complications, Infectious | 1 | 2020 | 11559 | 0.03 | Why? |
| Linear Models | 1 | 2021 | 1914 | 0.03 | Why? |
| Respiratory Function Tests | 1 | 2021 | 1755 | 0.03 | Why? |
| Antibodies | 1 | 2020 | 846 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.03 | Why? |
| Invasive Fungal Infections | 1 | 2017 | 274 | 0.03 | Why? |
| Encephalitis | 1 | 2020 | 797 | 0.03 | Why? |
| Follow-Up Studies | 2 | 2021 | 17020 | 0.03 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.03 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.03 | Why? |
| Combined Modality Therapy | 1 | 2021 | 3395 | 0.03 | Why? |
| Graft Rejection | 1 | 2021 | 1766 | 0.03 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.03 | Why? |
| Opportunistic Infections | 1 | 2017 | 602 | 0.03 | Why? |
| Family Characteristics | 1 | 2021 | 2551 | 0.03 | Why? |
| Delirium | 1 | 2020 | 1061 | 0.03 | Why? |
| Cost of Illness | 1 | 2021 | 1903 | 0.03 | Why? |
| Fatigue | 1 | 2021 | 2479 | 0.03 | Why? |
| Membrane Proteins | 1 | 2020 | 1733 | 0.02 | Why? |
| Case-Control Studies | 2 | 2020 | 17671 | 0.02 | Why? |
| Adult | 6 | 2021 | 244371 | 0.02 | Why? |
| Dyspnea | 1 | 2021 | 3847 | 0.02 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.02 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.02 | Why? |
| Prospective Studies | 2 | 2021 | 43301 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2020 | 9537 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2021 | 10017 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2020 | 9893 | 0.02 | Why? |
| France | 1 | 2020 | 12074 | 0.02 | Why? |
| Logistic Models | 1 | 2017 | 9089 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.01 | Why? |
| Europe | 1 | 2017 | 12702 | 0.01 | Why? |
| Risk Factors | 2 | 2021 | 71621 | 0.01 | Why? |
| Pregnancy | 1 | 2020 | 23879 | 0.01 | Why? |
| Critical Illness | 1 | 2021 | 17281 | 0.01 | Why? |
| Biomarkers | 1 | 2020 | 23361 | 0.01 | Why? |
| Incidence | 1 | 2018 | 25622 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2021 | 25144 | 0.01 | Why? |
| Prognosis | 1 | 2017 | 32490 | 0.01 | Why? |
| Treatment Outcome | 1 | 2017 | 51732 | 0.01 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.01 | Why? |
| Young Adult | 1 | 2020 | 93724 | 0.01 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.00 | Why? |
De Greef's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(111)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(97)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_